SCHEMBL31252137

SCHEMBL31252137

CC(C)(C)[Si](OCOC(=O)C1CCC1)(c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.43
▸ USP2 O75604 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ ELANE P08246 1/20 0.37
▸ HTR7 P34969 2/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ HTR2A P28223 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10437828 0.96 USP2 (0.43) ATMUSP2TSHRNPSR1ALDH1A1
SCHEMBL28410516 0.95 GAA (0.42) ATMUSP2TSHRNPSR1ALDH1A1
SCHEMBL17040981 0.79 ALDH1A1 (0.41) ATMTSHRNPSR1ALDH1A1KMT2A
SCHEMBL16351364 0.79 ALDH1A1 (0.43) ALDH1A1MAPTKMT2AHTTSMN1; SMN2
SCHEMBL29239698 0.78 ALDH1A1 (0.46) TSHRALDH1A1KMT2AHTTSMN1; SMN2
SCHEMBL28606626 0.77 KDM4E (0.36) TSHRALDH1A1MAPTKMT2AHTT
SCHEMBL38654078 0.76 GAA (0.39) TSHRNPSR1ALDH1A1MAPTKMT2A
SCHEMBL28388395 0.76 CYP4F2 (0.41) HTTSMN1; SMN2
SCHEMBL22070851 0.76 HSD11B1 (0.36) ATMUSP2NPSR1ALDH1A1MAPT
SCHEMBL26915222 0.76 ELANE (0.43) ATMALDH1A1KMT2AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720072-A2 RAS INHIBITORS Revolution Medicines, Inc. (US) 2026-04-08 — — EP disclosed
WO-2024249299-A2 RAS INHIBITORS Revolution Medicines, Inc. (US) 2024-12-05 — — WO disclosed
Send feedback